Online Pharmacy Regulation in India: A Cross Sectional Survey on Perceptions of Health Care Students/Professionals

Abstract

medicines. Some studies pointed out that many facilities lay weight on the frequency of prescription although they consider recommendations from clinical guidelines. In addition, several researches suggest the tendencies which they are more sensitive to medical cost, whereas quarter of them do not perform any pharmacoeconomic analysis. ConClusions: The paucity of research on development of HF suggests a lack of interest in the topic in Japan. In order to have a fair allocation of health and monetary resources, we need to review the role and making process of HF. Minimum requirements to develop Japanese HF should also be considered.

Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study

“…However, existing literatures indicate that JAS pharmacies have not achieved much popularity because of government’s inadequate support and poor campaigning, physicians prescribing brands and not generics, poor supply chain, and patient concerns about medicine quality [31, 32]. In this regard, India’s central and state governments should optimize JAS’s medicine list and supply chain, inform patients about the added value of obtaining medicines from JAS, mandate physicians to prescribe generics, and encourage patients to avail discounted insulin prices [33–36]. While online pharmacies could improve insulin access and affordability in India, this not-so-well-regulated sector has implications for insulin quality and supply chain security (see qualitative results) [36, 37].…”

“…In this regard, India’s central and state governments should optimize JAS’s medicine list and supply chain, inform patients about the added value of obtaining medicines from JAS, mandate physicians to prescribe generics, and encourage patients to avail discounted insulin prices [33–36]. While online pharmacies could improve insulin access and affordability in India, this not-so-well-regulated sector has implications for insulin quality and supply chain security (see qualitative results) [36, 37]. We recommend comprehensive evaluation and regulation of online pharmacies to harness the potential benefits.…”